In the pharmaceutical industry, maintaining the sterility and safety of drug products is paramount. Container closure integrity testing of prefilled syringes<\/strong> plays a critical role in verifying that a syringe’s sealing system effectively protects against contamination. As injectable drug products grow in popularity, ensuring container closure integrity (CCI) has become a regulatory expectation and a fundamental part of product development and quality control.<\/p>\n\n\n\n At Cell Instruments Co., Ltd., we understand the importance of accurate, reliable CCI testing. Our advanced equipment and customized solutions support pharmaceutical companies in meeting stringent quality standards.<\/p>\n\n\n\n Container closure integrity testing of prefilled syringes<\/strong> evaluates whether the syringe’s container and closure system maintain a sterile barrier throughout its shelf life. Breaches in integrity can lead to microbial contamination, compromised product quality, and potential risks to patient safety.<\/p>\n\n\n\n Different test methods exist to assess container closure integrity, including both deterministic and probabilistic approaches. Deterministic methods, preferred under current regulatory guidance, provide quantitative, reliable results with high sensitivity.<\/p>\n\n\n\n Prefilled syringes, often made from glass or polymer materials, can be vulnerable to mechanical stress, temperature changes, and material compatibility issues, making rigorous CCI testing critical throughout the product lifecycle.<\/p>\n\n\n\n
\n\n\n\nUnderstanding Container Closure Integrity Testing of Prefilled Syringes<\/h2>\n\n\n\n
Key reasons why CCI testing is essential:<\/h3>\n\n\n\n
\n
\n\n\n\n\u0f61\u0f74\u0f0b\u0f68\u0f7a\u0f66\u0f72\u0f0b\u0f54\u0f72\u0f0b \u0f21\u0f22\u0f20\u0f27<\/h2>\n\n\n\n